Nucleolin facilitates nuclear retention of an ultraconserved region containing <i>TRA2β4</i> and accelerates colon cancer cell growth

Yuzuru Satake, Yuki Kuwano, Tatsuya Nishikawa, Kinuyo Fujita, Saki Saijo, Miki Itai, Hiroki Tanaka, Kensei Nishida, Kazuhito Rokutan

Oncotarget · 2018 · 18 citations · 45 references

DOIFull text

Open access

Concepts

Abstract

// Yuzuru Satake 1 , Yuki Kuwano 1 , Tatsuya Nishikawa 1 , Kinuyo Fujita 1 , Saki Saijo 1 , Miki Itai 1 , Hiroki Tanaka 1 , Kensei Nishida 1 and Kazuhito Rokutan 1 1 Department of Pathophysiology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770&ndash;8503, Japan Correspondence to: Yuki Kuwano, email: kuwanoy@tokushima-u.ac.jp Keywords: nucleolin; transcribed-UCR; TRA2&beta;4; colon cancer; cell growth Abbreviations: TRA2&beta;: Transformer 2-beta; UCR: ultraconserved region; T-UCR: Transcribed-ultraconserved region; lncRNA: long noncoding RNA; qPCR: quantitative real-time polymerase chain reaction Received: November 02, 2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accepted: May 12, 2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Published: June 01, 2018 ABSTRACT Transcribed-ultraconserved regions (T-UCRs), which contain conserved sequences with 100% identity across human, rat and mouse species, are a novel category of functional RNAs. The human transformer 2&beta; gene ( TRA2B ) encodes a UCR that spans exon 2 (276 bp) and its neighboring introns. Among five spliced RNA variants ( TRA2&beta;1-5 ) transcribed from the TRA2B gene, only TRA2&beta;4 contains the conserved exon 2. TRA2&beta;4 is overexpressed in colon cancer cells and accelerates cell growth by blocking the transcription of CDKN1A . However, the mechanisms underlying the overexpression of TRA2&beta;4 in colon cancer cells are unknown. Using biotinylated RNA pull-down assays followed by liquid chromatography-mass spectrometric analysis, we identified nucleolin as a TRA2&beta;4 -binding protein. Knockdown of nucleolin reduced the nuclear retention of TRA2&beta;4 and accelerated its degradation in the cytoplasm, whereas nucleolin overexpression increased TRA2&beta;4 levels and its mitogenic activity. Nucleolin directly bound to TRA2&beta;4 exon 2 via the glycine/arginine-rich (GAR) domain. Overexpression of GAR-deficient nucleolin failed to increase TRA2&beta;4 expression and growth of colon cancer cells. RNA fluorescence in situ hybridization showed that TRA2&beta;4 co-localized with nucleolin in nuclei but not with the mutant lacking GAR. Our results suggest that specific interactions between nucleolin and UCR-containing TRA2&beta;4 may be associated with abnormal growth of colon cancer cells.

References

45